Vertical T cell immunodominance and epitope entropy determine HIV-1 escape

Journal of Clinical Investigation

Volumn 123, Issue 1, 2013, Pages 380-393

  Liu, Michael K P ^a   Hawkins, Natalie ^b   Ritchie, Adam J ^a   Ganusov, Vitaly V ^c   Whale, Victoria ^a   Brackenridge, Simon ^a   Li, Hui ^d   Pavlicek, Jeffrey W ^e   Cai, Fangping ^e   Rose Abrahams, Melissa ^f   Treurnicht, Florette ^f   Hraber, Peter ^g   Riou, Catherine ^f   Gray, Clive ^f   Ferrari, Guido ^e   Tanner, Rachel ^a   Ping, Li Hua ^h   Anderson, Jeffrey A ^h,i   Swanstrom, Ronald ^h,i   Cohen, Myron ^h   Karim, Salim S Abdool ^j   Haynes, Barton ^e   Borrow, Persephone ^k   Perelson, Alan S ^g,l   Shaw, George M ^d   Hahn, Beatrice H ^d   Williamson, Carolyn ^f   Korber, Bette T ^g,l   Gao, Feng ^e   Self, Steve ^b   McMichael, Andrew ^a   Goonetilleke, Nilu ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g LOS ALAMOS NATIONAL LABORATORY   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF KWAZULU NATAL   (South Africa)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l SANTA FE INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EPITOPE; HLA ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENTROPY; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNODOMINANCE; IN VIVO STUDY; INFECTION CONTROL; MALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS ESCAPE; VIRUS LOAD;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; IMMUNITY, CELLULAR; MALE;

EID: 84873830139     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65330     Document Type: Article

References (75)

1. Altfeld M, et al. HLA Alleles Associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med. 2006;3(10):e403.
2. Fellay J, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317(5840): 944-947.
3. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nature reviews. Immunology. 2010;10(1): 11-23.
4. Pereyra F, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010;330(6010): 1551-1557.
5. Barouch DH, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. 2002;415(6869): 335-339.
6. Schmitz JE, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283(5403): 857-860.
7. Draenert R, et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol. 2004;78(2): 630-641.
8. Altfeld M, et al. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol. 2003;77(13): 7330-7340.
9. Kiepiela P, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13(1): 46-53.
10. Goulder P, Price D, Nowak M, Rowland-Jones S, Phillips R, McMichael A. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev. 1997;159: 17-29.
11. Kaslow RA, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 1996;2(4): 405-411.
12. Leslie A, et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol. 2010;84(19): 9879-9888.
13. Dinges WL, et al. Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J Virol. 2010;84(9): 4461-4468.
14. Yewdell JW. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity. 2006;25(4): 533-543.
15. Chen W, Anton LC, Bennink JR, Yewdell JW. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity. 2000;12(1): 83-93.
16. Tscharke DC, et al. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med. 2005;201(1): 95-104.
17. Nowak MA, et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature. 1995;375(6532): 606-611.
18. Iversen AK, et al. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol. 2006;7(2): 179-189.
19. Jones NA, et al. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med. 2004;200(10): 1243-1256.
20. Goonetilleke N, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009;206(6): 1253-1272.
21. Oseroff C, et al. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. J Immunol. 2008;180(11): 7193-7202.
22. Yu XG, et al. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol. 2002;76(17): 8690-8701.
23. McMichael AJ, Gotch FM, Rothbard J. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J Exp Med. 1986;164(5): 1397-1406.
24. Streeck H, et al. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol. 2009;83(15): 7641-7648.
25. Turnbull EL, et al. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol. 2009;182(11): 7131-7145.
26. Borrow P, et al. Antiviral pressure exerted by HIV- 1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 1997;3(2): 205-211.
27. Goulder PJ, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997;3(2): 212-217.
28. Phillips RE, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991;354(6353): 453-459.
29. Price DA, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A. 1997;94(5): 1890-1895.
30. Fischer W, et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PloS One. 2010;5(8):e12303.
31. Ganusov VV, et al. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J Virol. 2011;85(20): 10518-10528.
32. Asquith B, Edwards CT, Lipsitch M, McLean AR. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 2006;4(4):e90.
33. Leslie AJ, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med. 2004;10(3): 282-289.
34. Kawashima Y, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature. 2009; 458(7238): 641-645.
35. Crawford H, et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLAB* 5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol. 2007;81(15): 8346-8351.
36. Martinez-Picado J, et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol. 2006;80(7): 3617-3623.
37. Miura T, et al. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol. 2010;84(15): 7581-7591.
38. Troyer RM, et al. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 2009;5(4):e1000365.
39. Ferrari G, et al. Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog. 2011;7(2):e1001273.
40. Shannon CE. A mathematical theory of communication. Bell Sys Tech J. 1948;27(3): 379-423.
41. Gaschen B, et al. Diversity considerations in HIV-1 vaccine selection. Science. 2002;296(5577): 2354-2360.
42. Allen TM, et al. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol. 2005;79(21): 13239-13249.
43. Keele BF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008;105(21): 7552-7557.
44. Altfeld M, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001;193(2): 169-180.
45. Mlotshwa M, et al. Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression. J Virol. 2010;84(22): 12018-12029.
46. Fiebig EW, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13): 1871-1879.
47. Fiebig EW, Heldebrant CM, Smith RI, Conrad AJ, Delwart EL, Busch MP. Intermittent low-level viremia in very early primary HIV-1 infection. J Acquir Immune Defic Syndr. 2005;39(2): 133-137.
48. Draenert R, et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med. 2004;199(7): 905-915.
49. Brumme ZL, et al. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol. 2008;82(18): 9216-9227.
50. O'Quigley J, Xu R, Stare J. Explained randomness in proportional hazards models. Stat Med. 2005;24(3): 479-489.
51. Brockman MA, et al. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol. 2007;81(22): 12608-12618.
52. Elemans M, Seich Al Basatena NK, Klatt NR, Gkekas C, Silvestri G, Asquith B. Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo? PLoS Comput Biol. 2011;7(9):e1002200.
53. Gallimore A, Dumrese T, Hengartner H, Zinkernagel RM, Rammensee HG. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med. 1998;187(10): 1647-1657.
54. van der Most RG, et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol. 1996;157(12): 5543-5554.
55. Betts MR, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107(12): 4781-4789.
56. Petrovas C, et al. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol. 2009;183(2): 1120-1132.
57. Makedonas G, et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog. 2010;6(3):e1000798.
58. Price DA, et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J Exp Med. 2009;206(4): 923-936.
59. Mendoza D, et al. HLA B*5701-positive longterm nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells. J Virol. 2012;86(7): 4014-4018.
60. Iglesias MC, et al. Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood. 2011;118(8): 2138-2149.
61. Chen H, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol. 2012;13(7): 691-700.
62. Hasegawa A, et al. Analysis of TCRalphabeta combinations used by simian immunodeficiency virus-specific CD8+ T cells in rhesus monkeys: implications for CTL immunodominance. J Immunol. 2007;178(6): 3409-3417.
63. Loffredo JT, et al. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J Virol. 2008;82(4): 1723-1738.
64. Loh L, et al. Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection. PLoS Pathog. 2009;5(4):e1000378.
65. Hecht FM, et al. HIV RNA level in early infection is predicted by viral load in the transmission source. AIDS. 2010;24(7): 941-945.
66. Alizon S, et al. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog. 2010;6(9):e1001123.
67. Goepfert PA, et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med. 2008;205(5): 1009-1017.
68. Chopera DR, et al. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 2008;4(3):e1000033.
69. Goulder PJ, Walker BD. The great escape - AIDS viruses and immune control. Nat Med. 1999; 5(11): 1233-1235.
70. Salazar-Gonzalez JF, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009;206(6): 1273-1289.
71. Abrahams MR, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol. 2009; 83(8): 3556-3567.
72. Roederer M, Koup RA. Optimized determination of T cell epitope responses. J Immunol Methods. 2003;274(1-2): 221-228.
73. Goonetilleke N, et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)- specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNAand modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol. 2006;80(10): 4717-4728.
74. Bunce M. PCR-sequence-specific primer typing of HLA class I and class II alleles. In: Powis SH, Vaughan RW, eds. MHC Protocols. Vol. 210. Totowa, New Jersey, USA: Human Press; 2003: 143-172.
75. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78(3): 691-692.